Benech, H.; Flament, V.; Lhotellier, C.; Roucairol, C.; Joudinaud, T.
New Insights into Drug Development via the Nose-to-Brain Pathway: Exemplification Through Dodecyl Creatine Ester for Neuronal Disorders. Pharmaceutics 2026, 18, 80.
https://doi.org/10.3390/pharmaceutics18010080
AMA Style
Benech H, Flament V, Lhotellier C, Roucairol C, Joudinaud T.
New Insights into Drug Development via the Nose-to-Brain Pathway: Exemplification Through Dodecyl Creatine Ester for Neuronal Disorders. Pharmaceutics. 2026; 18(1):80.
https://doi.org/10.3390/pharmaceutics18010080
Chicago/Turabian Style
Benech, Henri, Victoria Flament, Clara Lhotellier, Camille Roucairol, and Thomas Joudinaud.
2026. "New Insights into Drug Development via the Nose-to-Brain Pathway: Exemplification Through Dodecyl Creatine Ester for Neuronal Disorders" Pharmaceutics 18, no. 1: 80.
https://doi.org/10.3390/pharmaceutics18010080
APA Style
Benech, H., Flament, V., Lhotellier, C., Roucairol, C., & Joudinaud, T.
(2026). New Insights into Drug Development via the Nose-to-Brain Pathway: Exemplification Through Dodecyl Creatine Ester for Neuronal Disorders. Pharmaceutics, 18(1), 80.
https://doi.org/10.3390/pharmaceutics18010080